Growth Hormone in Neuroendocrine Dysfunction With Severe Fibromyalgia Syndrome
Clinical trial NCT00933686 · COMPLETED
Trial details
- NCT number
- NCT00933686
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-07-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.